Evidence map›Paper›PMID 42834630›Full record

ArticleJournal of microbiology and biotechnology2026

Non-Proliferative Immune Restoration by

Seung Woo Ahn, Yun Hwan Park, Chang Ho Cho, Seung Woo Jo, Mi Gyeong Lee, Yoon-E Choi

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seung Woo AhnDivision of Environmental Science and Ecological Engineering, Korea University, Seoul 02841, Republic of Korea.
Yun Hwan ParkDivision of Environmental Science and Ecological Engineering, Korea University, Seoul 02841, Republic of Korea.
Chang Ho ChoEuealbiotech Co., Ltd., Seoul 03980, Republic of Korea.
Seung Woo JoEuealbiotech Co., Ltd., Seoul 03980, Republic of Korea.
Mi Gyeong LeeEuealbiotech Co., Ltd., Seoul 03980, Republic of Korea.
Yoon-E ChoiDivision of Environmental Science and Ecological Engineering, Korea University, Seoul 02841, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytotoxic chemotherapy frequently induces immunosuppression, impairing the innate cellular and humoral immune responses. Therefore, immunomodulatory agents that restore immune function without indiscriminate leukocyte expansion are required. This study examined whether

Indexed as

CyclophosphamideEuglena gracilisImmunologic FactorsAnimalsCell ProliferationCytokinesGlucansImmunocompromised HostImmunoglobulinsImmunosuppression TherapyImmunosuppressive AgentsKiller Cells, NaturalLeukocyte CountMaleMiceMice, Inbred BALB CCyclophosphamideCytokinesGlucansImmunoglobulinsImmunologic FactorsImmunosuppressive AgentsparamylonPowdersCyclophosphamideImmunoglobulinImmunomodulationNatural killer cellParamylon

Identifiers

PMID42834630
PMCPMC13655588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.